MISMATCH REPAIR LOSS RENDERS ER+/HER2- BREAST CANCER SUSCEPTIBLE TO HER2/3 INHIBITION

$474,709FY2018Defense Health AgencyDOD

Baylor College Of Medicine, Houston TX

Investigators

MISMATCH REPAIR LOSS RENDERS ER+/HER2- BREAST CANCER SUSCEPTIBLE TO HER2/3 INHIBITION · GrantIndex